Brochures

GTC Brochures 2023

Heme Brochure 8.5x11 v.2.6 web
Hematology Brochure
Solid Tumor Brochure 8.5x11 v.2.6 web
Solid Tumor Brochure
GTC's Liquid Trace Brochure v.5.0
Liquid Trace Brochure
Pharma n Research Services Brochure v.2.0 web
Research and Pharma Services Brochure
Physicians Brochure v.3.14 web
Physicians Brochure
Prostate Cancer Case Study Brochure 8.5x11 v.1.2 web
Prostate Cancer Case Study Brochure
cfDNA Case Study Brochure
cfDNA Case Study Brochure
VEXAS Case Study Brochure
VEXAS Case Study Brochure
CUP Case Study Brochure
CUP Case Study Brochure
ESR1 Case Study Brochure 8.5x11
ESR1 Case Study Brochure
Case study Detection of Multiple Myeloma - Cover
Multiple Myeloma Case Study Brochure
CHIP - CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL -Brochure_2023
CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL

Published Posters

AACR 2023

Predicting PD-L1 status in solid tumors using transcriptomic data and artificial intelligence algorithms

Predicting PD-L1 Status in Solid Tumors Using Transcriptomic Data and Artificial Intelligence Algorithms

The molecular landscape of premenopausal versus postmenopausal breast cancer in patients without inherited predisposition mutations

The Molecular Landscape of Premenopausal Versus Postmenopausal Breast Cancer in Patients Without Inherited Predisposition Mutations

Real-world transcriptomic biomarkers as replacement for immunohistochemistry and FISH studies in breast cancer

ASCO 2022

Combining cell-free RNA (cfRNA) with cell-free total nucleic acid (cfTNA) as a new paradigm for liquid biopsy

Cell-free RNA in liquid biopsy and biomarkers profiling of hematologic and solid tumors

Differential diagnosis of hematologic and solid tumors using targeted transcriptome and artificial intelligence

ASH 2022

DNA AND RNA PROFILES IN MACHINE LEARNING ALGORITHM TO PREDICT WHICH PATIENTS WITH AML/MDS WILL RESPOND TO VENETOCLAX-BASED THERAPY

LIQUID IMMUNOPHENOTYPING
AND THE DIAGNOSIS OF LYMPHOID NEOPLASMS
USING CELL-FREE RNA

ASH 2021

Bone Marrow-Based Biomarkers for Predicting aGVHD Using Targeted RNA Next Generation Sequencing and Machine Learning

Reliability of Liquid Biopsy and Next Generation Sequencing in Monitoring Residual Disease Post-Hematopoietic Stem Cell Transplant

Determining Clinical Course of Diffuse Large B-cell lymphoma
Using Targeted Transcriptome
and Machine Learning Algorithms

Reliability of Cell-Free DNA (cfDNA) Next Generation Sequencing in Predicting Chromosomal Structural Abnormalities and Cytogenetic-Risk Stratification of Patients with Myeloid Neoplasms.